Yuyu Medimpex Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 35 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.00 M
as on 08-07-2024
- Revenue 9.75%
(FY 2020)
- Profit 17.09%
(FY 2020)
- Ebitda -7.60%
(FY 2020)
- Net Worth -16.69%
(FY 2020)
- Total Assets -15.67%
(FY 2020)
About Yuyu Medimpex
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹6.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Brinda Upadhyaya and Ajay Upadhyaya serve as directors at the Company.
- CIN/LLPIN
U51900MH1988PTC050158
- Company No.
050158
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Yuyu Medimpex Private Limited offer?
Yuyu Medimpex Private Limited offers a wide range of products and services, including Paper Work & Making Machine, Paper Machinery, Protective Packing Materials, Packaging Foam, Pharmaceutical Machinery & Equipment, Tablet Making Machines, Strapping & Sealing Machines, Carton Sealer, Labels: Adhesive, Fabric & Metal, Labels.
Who are the key members and board of directors at Yuyu Medimpex?
Executive Team (1)
AU
Ajay Upadhyaya
Managing DirectorAppointment Date: 23-Dec-1988
Status: Current
Board Members(1)
Financial Performance and Corporate Structure Insights of Yuyu Medimpex.
Yuyu Medimpex Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 9.75% increase. The company also saw a substantial improvement in profitability, with a 17.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yuyu Medimpex?
In 2019, Yuyu Medimpex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
1 year 9 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 16 Dec 2005 | ₹6.00 M | Satisfied |
How Many Employees Work at Yuyu Medimpex?
Unlock and access historical data on people associated with Yuyu Medimpex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yuyu Medimpex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yuyu Medimpex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
